Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Masferrer

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Journal of the National Cancer Institute|September 2, 1999
Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzymeL Milas, K Kishi, N Hunter, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
The biochemical and pharmacological manipulation of cellular cyclooxygenase (COX) activityK Seibert, J L Masferrer, J Y FU, et al.
Investigative Ophthalmology & Visual Science|March 1, 1989
Ocular effects of a novel cytochrome P-450-dependent arachidonic acid metaboliteJ L Masferrer, R C Murphy, P J Pagano, et al.
British Journal of Pharmacology|March 1, 1995
Regulation of prostaglandin production by nitric oxide; an in vivo analysisD Salvemini, S L Settle, J L Masferrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1993
Nitric oxide activates cyclooxygenase enzymesD Salvemini, T P Misko, J L Masferrer, et al.
The Journal of Clinical Investigation|May 1, 1994
Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammationD Salvemini, K Seibert, J L Masferrer, et al.
Cancer Research|March 23, 2000
Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitorK Kishi, S Petersen, C Petersen, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
Nitric oxide and the cyclooxygenase pathwayD Salvemini, K Seibert, J L Masferrer, et al.
Anticancer Research|February 19, 2002
Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesisH M Abou-Issa, G A Alshafie, K Seibert, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophagesJ L Masferrer, S T Reddy, B S Zweifel, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Journal of the National Cancer Institute|September 2, 1999
Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzymeL Milas, K Kishi, N Hunter, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
The biochemical and pharmacological manipulation of cellular cyclooxygenase (COX) activityK Seibert, J L Masferrer, J Y FU, et al.
Investigative Ophthalmology & Visual Science|March 1, 1989
Ocular effects of a novel cytochrome P-450-dependent arachidonic acid metaboliteJ L Masferrer, R C Murphy, P J Pagano, et al.
British Journal of Pharmacology|March 1, 1995
Regulation of prostaglandin production by nitric oxide; an in vivo analysisD Salvemini, S L Settle, J L Masferrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1993
Nitric oxide activates cyclooxygenase enzymesD Salvemini, T P Misko, J L Masferrer, et al.
The Journal of Clinical Investigation|May 1, 1994
Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammationD Salvemini, K Seibert, J L Masferrer, et al.
Cancer Research|March 23, 2000
Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitorK Kishi, S Petersen, C Petersen, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
Nitric oxide and the cyclooxygenase pathwayD Salvemini, K Seibert, J L Masferrer, et al.
Anticancer Research|February 19, 2002
Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesisH M Abou-Issa, G A Alshafie, K Seibert, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophagesJ L Masferrer, S T Reddy, B S Zweifel, et al.
Pageof 6